Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CNTA

Centessa Pharmaceuticals (CNTA)

Centessa Pharmaceuticals PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CNTA
DateTimeSourceHeadlineSymbolCompany
03/30/20237:46AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:CNTACentessa Pharmaceuticals PLC
03/30/20237:20AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTACentessa Pharmaceuticals PLC
03/30/20237:00AMGlobeNewswire Inc.Centessa Pharmaceuticals Reports Recent Business Progress and Financial Results for the Fourth Quarter and Full-Year 2022NASDAQ:CNTACentessa Pharmaceuticals PLC
03/27/20238:00AMGlobeNewswire Inc.Centessa Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:CNTACentessa Pharmaceuticals PLC
03/23/20234:30PMPR Newswire (US)Clarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent DirectorNASDAQ:CNTACentessa Pharmaceuticals PLC
03/23/20234:30PMPR Newswire (US)Clarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent DirectorNASDAQ:CNTACentessa Pharmaceuticals PLC
03/03/20235:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
03/01/20238:00AMGlobeNewswire Inc.Centessa Pharmaceuticals Announces Addition of Patrick Yue, MD, as Senior Vice President of Clinical Development, Innovative MedicinesNASDAQ:CNTACentessa Pharmaceuticals PLC
02/06/20238:00AMGlobeNewswire Inc.Centessa Pharmaceuticals to Present Additional Data from Open-Label Extension (OLE) of Phase 2a Study of SerpinPC for Hemophilia at the 16th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)NASDAQ:CNTACentessa Pharmaceuticals PLC
02/03/20235:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
02/03/20235:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
02/03/20235:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
02/03/20235:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
02/03/20235:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
02/03/20235:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
02/03/20235:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
02/02/20238:00AMGlobeNewswire Inc.Centessa Pharmaceuticals Announces Presentation at the SVB Securities Global Biopharma ConferenceNASDAQ:CNTACentessa Pharmaceuticals PLC
01/31/20234:00PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNTACentessa Pharmaceuticals PLC
01/27/20235:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTACentessa Pharmaceuticals PLC
01/27/20235:05PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CNTACentessa Pharmaceuticals PLC
01/26/202311:29AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTACentessa Pharmaceuticals PLC
01/26/20239:47AMDow Jones NewsCentessa Pharmaceuticals Gets FDA Clearance for LB101 Clinical TrialNASDAQ:CNTACentessa Pharmaceuticals PLC
01/26/20239:08AMGlobeNewswire Inc.Centessa Pharmaceuticals Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of LB101, First LockBody® Candidate, for Solid TumorsNASDAQ:CNTACentessa Pharmaceuticals PLC
01/13/20235:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
01/13/20235:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
01/13/20235:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
01/13/20235:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
01/13/20235:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
01/13/20235:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
12/23/20224:27PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTACentessa Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:CNTA

Your Recent History

Delayed Upgrade Clock